Argentina's Bioceres says its GMO wheat gets key OK from U.S. FDA

Bioceres Crop Solutions

27/06/2022 13:30

BUENOS AIRES, June 27 (Reuters) - Argentina's Bioceres
 BIOX.O  said on Monday that the U.S. Food and Drug
Administration had positively concluded a review of its
genetically modified (GMO) drought resistant HB4 wheat, which it
called a "key step" to commercializing it in the country.
    The HB4 wheat still needs approval from the U.S. Department
of Agriculture (USDA).
    "The FDA has concluded that it has no further questions
regarding the safety of HB4 wheat, and that it does not raise
issues that would require premarket review or approval by FDA,"
Bioceres said in a statement.
    "The conclusion of this voluntary consultation program is a
key step towards commercial enablement in the United States."
    The FDA, Environmental Protection Agency and USDA regulate
most GMOs in the United States. The FDA evaluates the safety of
food from new GMOs before they enter the market, while the USDA
makes sure GMO plants are not harmful to other plants.
    The FDA and USDA did not immediately respond to a request
for comment.




 (Reporting by Jorgelina do Rosario, Caroline Stauffer; Writing
by Adam Jourdan)
 ((adam.jourdan@thomsonreuters.com; +54 1155446882; Reuters
Messaging: adam.jourdan.thomsonreuters.com@reuters.net))